Patents by Inventor Jeffrey Scott Stults

Jeffrey Scott Stults has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Romidepsin solid forms and uses thereof
    Patent number: 9624271
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: April 18, 2017
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • Romidepsin solid forms and uses thereof
    Patent number: 9518094
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: December 13, 2016
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20160060300
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: November 10, 2015
    Publication date: March 3, 2016
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valeriya SMOLENSKAYA, Jeffrey Scott STULTS
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20150218225
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: February 5, 2015
    Publication date: August 6, 2015
    Inventors: Jason HANKO, David Alan ENGER, Eric HAGEN, Valeriya SMOLENSKAYA, Jeffrey Scott STULTS
  • Romidepsin solid forms and uses thereof
    Patent number: 8980825
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: March 17, 2015
    Assignee: Celgene Corporation
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valeriya Smolenskaya, Jeffrey Scott Stults
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20140336132
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 13, 2014
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valelriya SMOLENSKAYA, Jeffrey Scott STULTS
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20140256637
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: Celgene Corporation
    Inventors: Jason HANKO, David Alan ENGERS, Eric HAGEN, Valelriya SMOLENSKAYA, Jeffrey Scott STULTS, Vijay Harishchandra NARINGREKAR, Victor PEYKOV, William Rodney FOSS, Neil Lawrence DARLING, Nicholas VROLIJK
  • ROMIDEPSIN SOLID FORMS AND USES THEREOF
    Publication number: 20120046442
    Abstract: The present disclosure provides solid forms of a compound of formula I. In some embodiments, the present disclosure provides crystalline forms of Compound I. In some embodiments, the present disclosure provides solvate forms of Compound I. In some embodiments, the present disclosure provides amorphous Compound I.
    Type: Application
    Filed: July 12, 2011
    Publication date: February 23, 2012
    Inventors: Jason Hanko, David Alan Engers, Eric Hagen, Valenya Smolenskaya, Jeffrey Scott Stults
  • CRYSTALLINE HYDRATES OF CEFDINIR CALCIUM SALT
    Publication number: 20070208173
    Abstract: Crystalline hydrates of (6R-(6?,7?(Z))-7-((2-amino-4-thiazolyl)(hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cefdinir), calcium salt, ways to make them, compositions comprising them and made with them, and methods of treatment using them are disclosed.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 6, 2007
    Inventors: Ron Christopher Kelly, Jeffrey Scott Stults